[go: up one dir, main page]

RU2001128504A - Growth promoting compositions - Google Patents

Growth promoting compositions

Info

Publication number
RU2001128504A
RU2001128504A RU2001128504/14A RU2001128504A RU2001128504A RU 2001128504 A RU2001128504 A RU 2001128504A RU 2001128504/14 A RU2001128504/14 A RU 2001128504/14A RU 2001128504 A RU2001128504 A RU 2001128504A RU 2001128504 A RU2001128504 A RU 2001128504A
Authority
RU
Russia
Prior art keywords
inhibitor
dipeptidyl peptidase
dwarfism
composition
pharmaceutical composition
Prior art date
Application number
RU2001128504/14A
Other languages
Russian (ru)
Other versions
RU2242228C2 (en
Inventor
Пьер БРОКА
Original Assignee
Ферринг Б.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9906715.9A external-priority patent/GB9906715D0/en
Application filed by Ферринг Б.В. filed Critical Ферринг Б.В.
Publication of RU2001128504A publication Critical patent/RU2001128504A/en
Application granted granted Critical
Publication of RU2242228C2 publication Critical patent/RU2242228C2/en

Links

Claims (10)

1. Фармацевтическая композиция, предназначенная для лечения замедленного роста или карликовости, отличающаяся тем, что она включает в себя терапевтически эффективное количество ингибитора дипептидилпептидазы IV.1. A pharmaceutical composition for treating stunted growth or dwarfism, characterized in that it comprises a therapeutically effective amount of a dipeptidyl peptidase IV inhibitor. 2. Композиция по п.1, в которой замедленный рост или карликовость связаны с недостатком гормона роста.2. The composition according to claim 1, in which slow growth or dwarfism is associated with a lack of growth hormone. 3. Фармацевтическая композиция, предназначенная для стимуляции восстановления тканей, отличающаяся тем, что она включает в себя терапевтически эффективное количество ингибитора дипептидилпептидазы IV.3. A pharmaceutical composition intended to stimulate tissue repair, characterized in that it comprises a therapeutically effective amount of a dipeptidyl peptidase IV inhibitor. 4. Композиция по любому из предшествующих пунктов, в которой ингибитор дипептидилпептидазы IV содержит нитрил аминоацилпирролидина.4. A composition according to any one of the preceding claims, wherein the dipeptidyl peptidase IV inhibitor comprises aminoacylpyrrolidine nitrile. 5. Композиция по любому из предшествующих пунктов, которая изготовлена для перорального применения.5. The composition according to any one of the preceding paragraphs, which is made for oral use. 6. Композиция по п.5, изготовленная в виде таблетки или капсулы.6. The composition according to claim 5, made in the form of tablets or capsules. 7. Применение ингибитора дипептидилпептидазы IV для приготовления терапевтической композиции для лечения замедленного развития или карликовости или для стимуляции регенерации тканей.7. The use of a dipeptidyl peptidase IV inhibitor for the preparation of a therapeutic composition for the treatment of delayed development or dwarfism or for stimulating tissue regeneration. 8. Способ лечения замедленного развития или карликовости, при котором пациенту вводят фармацевтическую композицию, содержащую ингибитор дипептидилпептидазы IV.8. A method of treating delayed development or dwarfism, in which a pharmaceutical composition comprising a dipeptidyl peptidase IV inhibitor is administered to a patient. 9. Способ по п.8, при котором композицию вводят один раз в день, вечером.9. The method of claim 8, wherein the composition is administered once a day, in the evening. 10. Способ регенерации ткани, при котором пациенту вводят фармацевтическую композицию, содержащую ингибитор дипептидил-пептидазы IV.10. A tissue regeneration method in which a pharmaceutical composition comprising a dipeptidyl peptidase IV inhibitor is administered to a patient.
RU2001128504/15A 1999-03-23 2000-03-21 Growth-stimulating composition RU2242228C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9906715.9 1999-03-23
GBGB9906715.9A GB9906715D0 (en) 1999-03-23 1999-03-23 Compositions for promoting growth

Publications (2)

Publication Number Publication Date
RU2001128504A true RU2001128504A (en) 2003-06-27
RU2242228C2 RU2242228C2 (en) 2004-12-20

Family

ID=10850230

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001128504/15A RU2242228C2 (en) 1999-03-23 2000-03-21 Growth-stimulating composition

Country Status (26)

Country Link
US (1) US6521644B1 (en)
EP (1) EP1171121B1 (en)
JP (1) JP2002539244A (en)
KR (1) KR100704348B1 (en)
CN (1) CN1359293A (en)
AR (1) AR023130A1 (en)
AT (1) ATE297728T1 (en)
AU (1) AU772421B2 (en)
CA (1) CA2366926A1 (en)
CZ (1) CZ20013411A3 (en)
DE (1) DE60020825T2 (en)
GB (1) GB9906715D0 (en)
HK (1) HK1048589A1 (en)
HU (1) HUP0200391A3 (en)
IL (2) IL145568A0 (en)
MX (1) MXPA01009610A (en)
MY (1) MY124214A (en)
NO (1) NO20014608L (en)
NZ (1) NZ514450A (en)
PL (1) PL195529B1 (en)
RU (1) RU2242228C2 (en)
TR (1) TR200102648T2 (en)
TW (1) TWI239246B (en)
UA (1) UA73115C2 (en)
WO (1) WO2000056297A2 (en)
ZA (1) ZA200108082B (en)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040152745A1 (en) * 1999-11-12 2004-08-05 Guilford Pharmaceuticals, Inc. Dipeptidyl peptidase IV inhibitors and methods of making and using dipeptidyl peptidase IV inhibitors
GB9928330D0 (en) 1999-11-30 2000-01-26 Ferring Bv Novel antidiabetic agents
US6395767B2 (en) 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
US7196201B2 (en) * 2001-06-27 2007-03-27 Smithkline Beecham Corporation Pyrrolidines as dipeptidyl peptidase inhibitors
UA74912C2 (en) 2001-07-06 2006-02-15 Merck & Co Inc Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
AU2003297564A1 (en) * 2002-12-04 2004-06-23 Merck & Co., Inc. Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
US20040242566A1 (en) * 2003-03-25 2004-12-02 Syrrx, Inc. Dipeptidyl peptidase inhibitors
JP2007511467A (en) 2003-05-14 2007-05-10 タケダ サン ディエゴ インコーポレイテッド Dipeptidyl peptidase inhibitor
US7169926B1 (en) 2003-08-13 2007-01-30 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7678909B1 (en) 2003-08-13 2010-03-16 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
MXPA06001601A (en) * 2003-08-13 2006-08-25 Takeda Pharmaceutical 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors.
WO2005026148A1 (en) * 2003-09-08 2005-03-24 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
US20050065144A1 (en) * 2003-09-08 2005-03-24 Syrrx, Inc. Dipeptidyl peptidase inhibitors
US7732446B1 (en) 2004-03-11 2010-06-08 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
CN102127057A (en) * 2004-03-15 2011-07-20 武田药品工业株式会社 Dipeptidyl peptidase inhibitors
WO2005118555A1 (en) * 2004-06-04 2005-12-15 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
WO2006019965A2 (en) 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
EP1828192B1 (en) * 2004-12-21 2014-12-03 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
DOP2006000008A (en) 2005-01-10 2006-08-31 Arena Pharm Inc COMBINED THERAPY FOR THE TREATMENT OF DIABETES AND RELATED AFFECTIONS AND FOR THE TREATMENT OF AFFECTIONS THAT IMPROVE THROUGH AN INCREASE IN THE BLOOD CONCENTRATION OF GLP-1
KR20080000665A (en) * 2005-04-22 2008-01-02 알란토스 파마슈티컬즈 홀딩, 인코포레이티드 Dipeptidyl Peptidase-IV Inhibitors
US20070060529A1 (en) * 2005-09-14 2007-03-15 Christopher Ronald J Administration of dipeptidyl peptidase inhibitors
SI1931350T2 (en) * 2005-09-14 2021-11-30 Takeda Pharmaceutical Company Limited Administration of dipeptidyl peptidase inhibitors
SI1942898T2 (en) * 2005-09-14 2014-08-29 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors for treating diabetes
TW200745080A (en) * 2005-09-16 2007-12-16 Takeda Pharmaceuticals Co Polymorphs of tartrate salt of 2-[2-(3-(R)-amino-piperidin-1-yl)-5-fluoro-6-oxo-6H-pyrimidin-1-ylmethyl]-benzonitrile and methods of use therefor
EP1924567B1 (en) 2005-09-16 2012-08-22 Takeda Pharmaceutical Company Limited Process for the preparation of pyrimidinedione derivatives
TW200745079A (en) * 2005-09-16 2007-12-16 Takeda Pharmaceuticals Co Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
JP2009531456A (en) * 2006-03-28 2009-09-03 武田薬品工業株式会社 Preparation of (R) -3-aminopiperidine dihydrochloride
PE20071221A1 (en) 2006-04-11 2007-12-14 Arena Pharm Inc GPR119 RECEPTOR AGONISTS IN METHODS TO INCREASE BONE MASS AND TO TREAT OSTEOPOROSIS AND OTHER CONDITIONS CHARACTERIZED BY LOW BONE MASS, AND COMBINED THERAPY RELATED TO THESE AGONISTS
RS51965B (en) * 2006-09-13 2012-02-29 Takeda Pharmaceutical Company Limited USE 2-6- (3-AMINO-PIPERIDIN-1-IL) -3-METHYL-2,4-DIOXO-3,4-DIHYDRO-2H-PYRIMIDIN-1-ILMETHYL-4-FLUORO-BENZONITRIL FOR THE TREATMENT OF DIABETES, Cancers, autoimmune disorders and HIV infections
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
TW200838536A (en) * 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
EP2146210A1 (en) 2008-04-07 2010-01-20 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
JO2870B1 (en) 2008-11-13 2015-03-15 ميرك شارب اند دوهم كورب Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
AR077642A1 (en) 2009-07-09 2011-09-14 Arena Pharm Inc METABOLISM MODULATORS AND THE TREATMENT OF DISORDERS RELATED TO THE SAME
EP2473047B1 (en) 2009-09-02 2014-08-13 Merck Sharp & Dohme Corp. Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
WO2011079778A1 (en) 2009-12-30 2011-07-07 China Shanghai Fochon Pharmaceutical Co Ltd 3-(3-aminopiperidin-1-yl)-5-oxo-1,2,4-triazine derivates as dipeptidyl peptidase iv(dpp-iv) inhibitors
WO2011103256A1 (en) 2010-02-22 2011-08-25 Merck Sharp & Dohme Corp. Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
WO2011127051A1 (en) 2010-04-06 2011-10-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
US8980929B2 (en) 2010-05-21 2015-03-17 Merck Sharp & Dohme Corp. Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
MX2013003184A (en) 2010-09-22 2013-06-07 Arena Pharm Inc Modulators of the gpr119 receptor and the treatment of disorders related thereto.
WO2012135570A1 (en) 2011-04-01 2012-10-04 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012145361A1 (en) 2011-04-19 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
US20140051714A1 (en) 2011-04-22 2014-02-20 Arena Pharmaceuticals, Inc. Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto
WO2012145603A1 (en) 2011-04-22 2012-10-26 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2012170702A1 (en) 2011-06-08 2012-12-13 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013055910A1 (en) 2011-10-12 2013-04-18 Arena Pharmaceuticals, Inc. Modulators of the gpr119 receptor and the treatment of disorders related thereto
WO2013122920A1 (en) 2012-02-17 2013-08-22 Merck Sharp & Dohme Corp. Dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
US9315508B2 (en) 2012-07-23 2016-04-19 Merck Sharp & Dohme Corp. Treating diabetes with dipeptidyl peptidase-IV inhibitors
WO2014074668A1 (en) 2012-11-08 2014-05-15 Arena Pharmaceuticals, Inc. Modulators of gpr119 and the treatment of disorders related thereto
CA2979033A1 (en) 2015-03-09 2016-09-15 Intekrin Therapeutics, Inc. Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
CN110996951A (en) 2017-04-03 2020-04-10 科赫罗斯生物科学股份有限公司 PPARγ agonists for the treatment of progressive supranuclear palsy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2063360T3 (en) * 1989-06-16 1995-01-01 Upjohn Co POWERFUL GRF ANALOGS, STABILIZED.
EP0528858B1 (en) 1990-04-14 1997-01-22 New England Medical Center Hospitals, Inc. Inhibitors of dipeptidyl-aminopeptidase type iv
HUT63857A (en) * 1990-11-14 1993-10-28 Upjohn Co Process for producing grf-analogs
AU662508B2 (en) * 1990-12-13 1995-09-07 Pharmacia & Upjohn Company Fusion polypeptides
JPH0543453A (en) * 1991-08-20 1993-02-23 Sumitomo Pharmaceut Co Ltd Local sustained-release preparation for accelerating wound curing
HUT67319A (en) * 1991-08-30 1995-03-28 Life Medical Sciences Inc Compositions for treating wounds
ES2153831T3 (en) 1991-10-22 2001-03-16 New England Medical Center Inc TYPE IV DIPEPTIDIL-AMINOPEPTIDASE INHIBITORS.
IL111785A0 (en) * 1993-12-03 1995-01-24 Ferring Bv Dp-iv inhibitors and pharmaceutical compositions containing them
JPH09295946A (en) * 1995-05-16 1997-11-18 Mitsui Pharmaceut Inc Pharmaceutical composition
JPH09308259A (en) * 1996-05-17 1997-11-28 Toshiba Lighting & Technol Corp Power supply device, discharge lamp lighting device, and lighting device
TW492957B (en) * 1996-11-07 2002-07-01 Novartis Ag N-substituted 2-cyanopyrrolidnes
US5952301A (en) 1996-12-10 1999-09-14 1149336 Ontario Inc. Compositions and methods for enhancing intestinal function

Similar Documents

Publication Publication Date Title
RU2001128504A (en) Growth promoting compositions
WO2003073981A3 (en) Novel of cytokine inhibitors
RU2001128507A (en) Fertility Improving Compositions
IL189546A0 (en) Therapy for the treatment of disease
CA2366911A1 (en) Compositions for improving fertility
TWI367751B (en) Pharmaceutical composition comprising rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction
WO2004045593A3 (en) Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
WO2005058233A3 (en) Methods for treatment of acute pancreatitis
WO2005081742A3 (en) Testosterone oral dosage formulations and associated methods
RU2004135563A (en) MEDICINE FOR TREATING AN INCREASED ACTIVITY OF THE BLADDER
SE0400184D0 (en) New therapeutic use
WO2004039325A3 (en) Treatment of pain with jnk inhibitors
JP2005507892A5 (en)
EP1677806A4 (en) Methods for treating acute and overuse sprain and strain using hyaluronic acid
PL342099A1 (en) Therapeutic agents
CA2534577A1 (en) Method for promoting bone growth
SE9902597D0 (en) New use
NZ594154A (en) Transdermal administration of buprenorphine for preoperative treatment of post operative pain
RU2005131578A (en) APLIDINE FOR TREATMENT OF MULTIPLE MYELOMA
MXPA01012936A (en) Pharmaceutical composition containing sibutramine and orlistat.
JP2005501108A5 (en)
SE0200598D0 (en) Pharmaceutical composition and method of treatment or prevention of vascular disease or states of tissue hypoperfusion with hypoxic and / or ischemic consequences
RU2002122703A (en) METHOD FOR TREATING INFLAMMATORY AND INFLAMMATORY DESTRUCTIVE PERIODONTAL DISEASES
WO2004073627A3 (en) Novel therapeutic method and compositions for topical administration
MD1469G2 (en) Method of treatment of the burn shock